Probi postpones year-end report 2024

The Board of Directors of Probi AB (publ) has decided to postpone the reporting of the year-end report 2024 to February 28, 2025, due to the public takeover offer by Symrise.

The date for report of the year-end report was previously communicated to January 28, 2024. 

ABOUT PROBI
Probi® is a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food. Founded on science, and together with customers and research partners, Probi is striving towards a future in which as many people as possible can take control of their gut microbiome - so that they can live better lives for longer. Since its founding in 1991 at Sweden’s Lund University, Probi has expanded its operations to more than 40 markets, and holds more than 400 patents globally. Probi had sales of 628 MSEK in 2023. Probi's shares are listed on Nasdaq Stockholm, Mid-cap, and there were around 3,400 shareholders on December 31, 2023.